Bahnisikha Barman

Bahnisikha Barman

Auto-generated profile, based on publicly available information

Bahnisikha Barman

Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BBBahnisikha Barman
Bahnisikha Barman
Suvendra Nath BhattacharyyaSuvendra Nath Bhattacharyya
Suvendra Nath Bhattacharyya
MicroRNA (miRNA) binds to the 3′-UTR of its target mRNAs to repress protein synthesis. Extensive research was done to understand the mechanism of miRNA-mediated repression in animal cells. Considering the progress in understanding the mechanism, information about the subcellular sites of miRNA-mediated repression is surprisingly limited. In this study, using an inducible expression system for an miRNA target message, we have delineated how a target mRNA passes through polysome association and Ago2 interaction steps on rough endoplasmic reticulum (ER) before the miRNA-mediated repression sets in. From this study, de novo formed target mRNA localization to the ER-bound polysomes manifested as the earliest event, which is followed by Ago2 micro-ribonucleoprotein binding, and translation repression of target message. Compartmentalization of this process to rough ER membrane ensures enrichment of miRNA-targeted messages and micro-ribonucleoprotein components on ER upon reaching a steady state.

1 February 2017 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
MBMainak Bose
Mainak Bose
BBBahnisikha Barman
Bahnisikha Barman
AGAVIJIT GOSWAMI
AVIJIT GOSWAMI
Suvendra Nath BhattacharyyaSuvendra Nath Bhattacharyya
Suvendra Nath Bhattacharyya
MiRNA-mediated repression control expression of more than half of protein coding genes in metazoan animals. Translation repression is associated with target mRNA degradation initiated by decapping and deadenylation of the repressed mRNAs. Earlier evidence suggest Endoplasmic Reticulum (ER) as the site where miRNPs interact with their targets before the translation repression sets in but the subcellular location of subsequent degradation of miRNA-repressed messages is largely unidentified. Here, we explore the subcellular distribution of essential components of degradation machineries of miRNA-targeted mRNAs. We have noted that interaction of target mRNAs with AGO2 protein on ER precedes the relocalization of repressed messages to Multivesicular Bodies (MVBs). The repressed messages subsequently get deadenylated, lose their interaction with AGO2 and also become decapped. Blocking maturation of endosomes to late endosome and MVBs by targeting the endosomal protein HRS, uncouples miRNA-mediated translation repression from target RNA degradation. HRS is also targeted by the intracellular parasite Leishmania donovani (Ld) that curtails HRS level in infected cells to prevent uncoupling of mRNA-AGO2 interaction, prevent degradation of translationally repressed messages and thus stop recycling of miRNPs pre-engaged in repression.

14 January 2020 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
MBMainak Bose
Mainak Bose
SCSusanta Chatterjee
Susanta Chatterjee
YCYogaditya Chakrabarty
Yogaditya Chakrabarty
BBBahnisikha Barman
Bahnisikha Barman
Suvendra Nath BhattacharyyaSuvendra Nath Bhattacharyya
Suvendra Nath Bhattacharyya
MicroRNAs are short regulatory RNAs in metazoan cells. Regulation of miRNA activity and abundance is evident in human cells where availability of target messages can influence miRNA biogenesis by augmenting the Dicer1-dependent processing of precursors to mature microRNAs. Requirement of subcellular compartmentalization of Ago2, the key component of miRNA repression machineries, for the controlled biogenesis of miRNPs is reported here. The process predominantly happens on the polysomes attached with the endoplasmic reticulum for which the subcellular Ago2 trafficking is found to be essential. Mitochondrial tethering of endoplasmic reticulum and its interaction with endosomes controls Ago2 availability. In cells with depolarized mitochondria, miRNA biogenesis gets impaired, which results in lowering of de novo–formed mature miRNA levels and accumulation of miRNA-free Ago2 on endosomes that fails to interact with Dicer1 and to traffic back to endoplasmic reticulum for de novo miRNA loading. Thus, mitochondria by sensing the cellular context regulates Ago2 trafficking at the subcellular level, which acts as a rate-limiting step in miRNA biogenesis process in mammalian cells.

1 January 2022 in Contact: The Journal of Inter-Organelle Communication
Verified
Journal Article
Open access
BBBahnisikha Barman
Bahnisikha Barman
TDT. Renee Dawson
T. Renee Dawson
AWAlissa M. Weaver
Alissa M. Weaver
The mechanisms by which cytoplasmic cargoes such as RNAs are incorporated into extracellular vesicles (EVs) are poorly understood. In a recent article published in Developmental Cell, we describe a novel function of endoplasmic reticulum membrane contact sites (ER MCS) in regulating biogenesis of RNA-containing EVs (Barman et al., 2022). We identified the ER MCS tether protein VAP-A and the ceramide transporter CERT as key drivers of this process. VAP-A depletion and overexpression produced corresponding changes in the overall number and RNA content of secreted EVs. Further sub-fractionation of small EVs from VAP-A depleted cells revealed a distinct loss in a specific subset of dense, RNA-loaded small EVs that are critical for the transfer of miR-100 to recipient cells. Cell imaging data confirmed the loss of RNA and RNA binding proteins (RBPs) in VAP-A-knockdown multivesicular bodies. Lipid analysis of VAP-A-knockdown EVs revealed decreases in ceramides, which are known to affect EV biogenesis. Depletion of the ceramide transfer protein CERT, which interacts with its binding partner VAP-A at ER MCS, leads to similar defects in EV number and RNA content as VAP-A-knockdown. These data suggest a model for ER MCS as platforms for biogenesis of a key EV population via ceramide transfer and RNA loading.